The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: A single academic center case series

Journal of Crohn's and Colitis

Volumn 8, Issue 6, 2014, Pages 480-488

  Afzali, Anita ^a,b   Wheat, Chelle L ^b   Hu, Jie Kate ^c   Olerud, John E ^c   Lee, Scott D ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Biologic therapy; Crohn's enterocolitis; Cutaneous manifestations; Dermatologic reactions; Psoriasiform rash; Ulcerative colitis

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; STEROID; IMMUNOGLOBULIN F(AB) FRAGMENT; MACROGOL DERIVATIVE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PUSTULOSIS PALMOPLANTARIS; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; ULCERATIVE COLITIS; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COLITIS, ULCERATIVE; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; RASH;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; COLITIS, ULCERATIVE; CROHN DISEASE; EXANTHEMA; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFLAMMATORY BOWEL DISEASES; MALE; POLYETHYLENE GLYCOLS; PSORIASIS; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899948126     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.10.013     Document Type: Article

References (14)

1. Tracey D., Klareskog L., Sasso E.H., Salfeld J.G., Tak P.P. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2008, 117:244-279.
2. Collamer A.N., Battafarano D.F. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum 2010, 40:233-240.
3. Cullen G., Kroshinsky D., Cheifetz A.S., Korzenik J.R. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature. Aliment Pharmacol Ther 2011, 34:1318-1327.
4. Fiorino G., Allez M., Malesci A., Danese S. Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2009, 29:921-927.
5. Rahier J.F., Buche S., Peyrin-Biroulet L., Bouhnik Y., Duclos B., Louis E., et al. Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Clin Gastroenterol Hepatol 2010, 8:1048-1055.
6. Torres J., Buche S., Delaporte E., Colombel J.F. Skin side effects of inflammatory bowel disease therapy. Inflamm Bowel Dis 2013, 19(5):1086-1098.
7. Denadai R., Teixeira F.V., Steinwurz F., Romiti R., Saad-Hossne R. Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: a systematic literature review based on 222 cases. J Crohns Colitis 2013, 7(7):517-524.
8. Harrison M.J., Dixon W.G., Watson K.D., King Y., Groves R., Hyrich K.L., et al. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2009, 68:209-215.
9. Tillack C., Ehmann L.M., Friedrich M., Laubender R.P., Papay P., Vogelsang H., et al. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterized by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. Gut 2013, 00:1-21. [Epub].
10. Brandt E.B., Sivaprasad U. Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2011, 2(3):110.
11. Lowes M.A., Kikuchi T., Fuentes-Duculan J., Cardinale I., Zaba L.C., Haider A.S., et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008, 128(5):1207-1211.
12. Feng T., Qin H., Wang L., Benveniste E.N., Elson C.O., Cong Y. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. J Immunol 2011, 186(11):6313-6318.
13. Fiorentino D.F. The yin and yang of TNF alpha inhibition. Arch Dermatol 2007, 143:233-236.
14. Cuchacovich R., Espinoza C.G., Virk Z., Espinoza L.R. Biologic therapy (TNF-α antagonists)-induced psoriasis: a cytokine imbalance between TNF-α and IFN-α?. J Clin Rheumatol 2008, 14:353-356.